Exagen Profit Margin

Exagen (XGN) currently reports a profit margin of -26.61% as of June 2026. That compares with -28.85% in the prior-year period — up 7.8% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Exagen's profit margin history and peer comparisons.

Exagen's profit margin increased from -28.85% to -26.61% — a 7.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exagen's profit margin of -26.61% is lower than the Healthcare sector average of 13.89%. That is roughly 291.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Exagen's current -26.61% should be judged against Healthcare norms (sector average: 13.89%) and against XGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -26.61%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Exagen, and consider following XGN for alerts when major investors trade the stock.